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Drug addiction is a brain disease involving alterations in anatomy and functional neu-
ral communication. Drug intake and toxicity show daily rhythms in both humans and 
rodents. Evidence concerning the role of clock genes in drug intake has been previously 
reported. However, the implication of a timekeeping brain locus is much less known. 
The epithalamic lateral habenula (LHb) is now emerging as a key nucleus in drug intake 
and addiction. This brain structure modulates the activity of dopaminergic neurons from 
the ventral tegmental area, a central part of the reward system. Moreover, the LHb has 
circadian properties: LHb cellular activity (i.e., firing rate and clock genes expression) 
oscillates in a 24-h range, and the nucleus is affected by photic stimulation and has ana-
tomical connections with the main circadian pacemaker, the suprachiasmatic nucleus. 
Here, we describe the current insights on the role of the LHb as a circadian oscillator 
and its possible implications on the rhythmic regulation of the dopaminergic activity and 
drug intake. These data could inspire new strategies to treat drug addiction, considering 
circadian timing as a principal factor.
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THe CiRCADiAn SYSTeM
Environmental signals are rhythmic and organisms have to adapt to daily changes imposed by the 
day–night alternation. Species have, therefore, developed timekeeping mechanisms that are regulated 
by circadian (circa = close to, dien = day) clocks in almost any cell. These clocks are able to oscillate 
in a self-sustained manner with a periodicity close to a day (24 h), and to transmit time information 
to the rest of the body through specific output pathways (1).
The mammalian hypothalamus contains the principal circadian clock in the suprachiasmatic 
nucleus [SCN; (2)], which controls most of the behavioral and physiological rhythms (e.g., locomo-
tor activity, hormone secretion). In every SCN cell, the clockwork is dependent on an oscillatory 
mechanism formed from transcription-translational feedback loops in which the expression of 
clock genes like, Clock, Bmal1, Per (1–3), Cry (1–2), and Rev-erbα, and their respective proteins, 
runs around 24 h (3).
Abbreviations: CPP, conditioned preference place; DA, dopamine; DBS, deep brain stimulation; FR, fasciculus retroflexus; 
Hb, habenula; LHb, lateral habenula; MHb, median habenula; mPFC, medial prefrontal cortex; NAc, nucleus accumbens; 
PK2, prokineticine2; RMTg, rostromedian tegmentum nucleus; SCN, suprachiasmatic nucleus; VTA, ventral tegmental area.
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Light is the most important synchronizer for the SCN, this 
relays on a direct pathway from the photosensitive retinal gan-
glion cells that use the photopigment melanopsin (4). Besides 
light stimulation, non-photic time cues, such as exercise, food 
restriction, or drug intake, are able to affect or synchronize the 
SCN clock activity as well (5–7).
THe CLOCK On DRUGS
In humans and animals, drug intake often results in disruptions of 
daily rhythms [e.g., locomotor activity, sleep–wake cycle, eating 
habits; (5, 8)]. In rodents, several drugs of abuse like metham-
phetamine, cocaine, ethanol, and morphine affect the period of 
circadian rhythms of behavior and physiology [e.g., locomotion, 
body temperature (5, 8, 9)].
Furthermore, people with perturbations of the circadian 
system [e.g., shift-workers, people experiencing frequent jet-lags; 
(10)], or animal models with disruptions of the body clock [e.g., 
chronic jet-lag exposure; (11)] show an increase of drug intake 
(e.g., psychostimulants). For example, shift-workers use metham-
phetamine to avoid sleepiness and perform tasks accurately dur-
ing their working hours. Methamphetamine intake occurs mainly 
at the beginning of the active phase regardless of the day–night 
period (10), suggesting that drug intake may have a synchronizer 
role for the circadian clock (8).
Reciprocally, the circadian system modulates the behavioral 
responses to drug intake. In some clinical reports drug overdoses 
and toxicity have been showed to be clock-dependent (12–14). In 
rodents, behavioral sensitization and reward responses (measured 
by a conditioned place preference, CPP) to chronic injections 
of cocaine are significantly higher when animals are treated in 
the early day than at dusk or night (15, 16). Furthermore, some 
studies showed that the hormone melatonin, which is secreted at 
night, modulates the day–night variations in cocaine sensitiza-
tion and CPP in mice (16–19).
In rats, cocaine self-administration or alcohol intake shows a 
daily rhythm with higher consumption during the night (20–22). 
Nonetheless, for cocaine, daily rhythms are observed only when 
access is restricted to two or three intakes per hour. Over three 
intakes/h drug intake increases and the rhythm is disrupted (20). 
Interestingly, under constant darkness conditions, a circadian 
rhythm of cocaine intake emerges with a higher consumption at 
night, indicating that an endogenous clock regulates the circadian 
activity of cocaine intake (23).
Circadian genes from the molecular clockwork regulate drug 
intake and drug-related behaviors. Mutations of the genes Per2 
or Clock (e.g., ClockΔ19 mice) lead to higher behavioral responses 
(e.g., CPP and behavioral sensitization) to chronic injections of 
cocaine, and an increase in alcohol consumption (15, 24–26). 
Interestingly, animals lacking the gene Per1 or Npas2 (a homolog 
of the Clock gene) are behaviorally less sensitive to cocaine (15, 
27), showing opposite effects to drug intake to those observed 
in Per2 and Clock mutants. Together, these data suggest an 
important link between drug intake, the circadian system, and 
the master clock in the SCN.
Although the SCN is the principal pacemaker, other circa-
dian oscillators in the brain and peripheral organs are present 
(28). More importantly, in brain structures regulating reward 
and behavior, circadian oscillations with a similar molecular 
machinery to the SCN have been reported (28–30). This suggests 
that, beyond the SCN, a multi-oscillatory circadian system in the 
mammalian brain composed of the reward centers, inter alia, may 
regulate behavior and drug intake (31).
THe HABenULA
The habenula (Hb) is a brain region, which with the pineal gland 
forms the epithalamus. It is an interesting structure involved in 
the control of behavior (32). The Hb is located dorsally along the 
third ventricle close to the dorso-medial thalamus. It is mainly 
divided into two regions: the median Hb (MHb) and the lateral 
Hb (LHb) nuclei. Both regions receive forebrain information via 
the fibers of the stria medullaris and project to the midbrain via 
the efferent fibers of the fasciculus retroflexus (FR). The MHb 
and LHb contain sub-nuclei that differ in their receptors, cell 
morphology, anatomical and functional inputs and outputs, and 
neurotransmitters (33–36).
The LHb is a relay structure and, according to Hikosaka (37), 
its role is mainly related to the suppression of motor activity. 
However, several studies showed that the LHb is involved in other 
brain functions, such as reward, aversion, cognition, maternal 
behavior, sleep, and circadian rhythms, and in brain dysfunc-
tions, such as addiction, depression, and schizophrenia (35–38).
The LHb in the Dopamine Circuitry: 
implications in Addiction
The reward system is an intricate network involving diverse struc-
tures. The keystone of this circuit is the communication between 
the ventral tegmental area (VTA) and the nucleus accumbens 
(NAc). Dopaminergic neurons of the lateral VTA, which project 
to the lateral part of the NAc, encode for reward or for aversion 
depending on the dopamine (DA) receptors involved (39). Few 
studies reported NAc projections to LHb cells (40), although this 
has to be confirmed. Furthermore, the medial prefrontal cortex 
(mPFC) receives DAergic fibers from the medial VTA and sends 
glutamatergic projections to the NAc and LHb [(36, 39, 41); 
Figure 1].
The VTA is known to be a DAergic source, although some 
VTA neurons also contain GABA and glutamate. In this regard, 
some studies reported that the LHb is innervated by DAergic 
fibers and also by glutamate and GABAergic projections from 
the medial and lateral part of the VTA, respectively (42–45). In 
humans, there is a functional correlation between the LHb and 
VTA during aversion process, indicating a strong coupling of 
these structures (46). Thus, VTA-GABAergic transmission to 
the LHb may encode reward, while glutamatergic transmission 
results in aversion [(47); Figures 1A,B].
LHb neurons, which are mainly glutamatergic, are activated 
by an aversive cue, an unrewarding task or an error of prediction 
(i.e., absence of expected reward), and they are inhibited by an 
expected or unexpected reward (32, 48). Interestingly, DAergic 
VTA neurons behave the other way round in the presence of a 
reward or an aversive stimulus (32, 49, 50). Glutamatergic LHb 
FiGURe 1 | Simplified circuitry of reward and aversive responses of the LHb to drug intake. (A) Acute injections of cocaine activate the lateral VTA inducing 
DA release to the lateral NAc (shell) leading in a reward response. The LHb receives GABAergic and DAergic fibers from the VTA that inhibit the LHb. (B) Cocaine 
also has a delayed aversive effect that follows the reward response. Here, the LHb is activated by several glutamatergic excitatory inputs from BG, mPFC, and 
medial VTA that will be facilitated by cocaine. BG, basal ganglia; Med, median; mPFC, medial prefrontal cortex; Lat, lateral.
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projections terminate mostly on the rostromedial tegmentum 
nucleus (RMTg), which is a GABAergic nucleus inhibiting the 
lateral VTA, which then projects to the NAc (41, 51). Thus, 
the LHb–RMTg–VTA circuit predicts appetitive or aversive 
outcomes. There are also few LHb glutamatergic fibers directly 
innervating DAergic neurons of the medial VTA which modu-
late the activity of the mPFC to drive aversion [(41, 43, 51); 
Figures 1A,B].
Cocaine intake has an initial rewarding effect, which depends 
on the DAergic circuit to the NAc, which is followed by a negative 
effect in which glutamate might play an important role. Due to the 
close functional relationship of the LHb with the DAergic reward 
system, its implication in positive and negative effects of drug 
intake has been extensively studied. The LHb is a structure very 
sensitive to cocaine. A low dose of cocaine increases the glucose 
uptake in this region in rats (52). In  vivo and in  vitro cocaine 
exposure leads to an inhibitory (reward effect) or a biphasic firing 
rate response of the LHb. This LHb biphasic response (inhibitory 
then an excitatory effect) represents the reward and aversive 
states after cocaine intake, respectively [(53); Figures  1A,B]. 
Moreover, cocaine induces an increase of AMPA receptors in the 
LHb that facilitates glutamatergic inputs (from the VTA, basal 
ganglia, or mPFC), leading to LHb hyperactivity and hyperexcit-
ability (Figure 1B). This LHb hyperactivity might have a feedback 
role to prevent a higher activation of the VTA [(36, 43, 54–59); 
Figure 1B].
The role of the LHb in drug intake has also been highlighted in 
studies using lesions. LHb-ablated animals do not extinct drug-
seeking behavior while cocaine intake is not affected, suggesting 
that animals are not able to decrease drug-seeking even if there 
are no more rewarding effects (60). Voluntary ethanol intake is 
higher in rats with LHb lesions than that in sham control animals 
(61). In sum, these results show the important role of the LHb in 
the regulation of drug-directed behaviors and in the mediation 
of drug intake effects.
The MHb seems to play a role in the regulation of behavior 
and drug addiction as well. Mainly the MHb has been implicated 
in nicotine addiction (62). However, in mice with lesions of the 
dorsal part of the MHb, voluntary motor activity and sucrose 
preference are affected, suggesting an important role of the MHb 
in diverse motivated behaviors (63). Moreover, MHb inhibition 
by the antagonists of nicotinic receptors or optogenetic manipu-
lations blocks drug self-administration (e.g., cocaine, morphine, 
alcohol) or leads to an aversive response, respectively (62, 63).
Hence, habenular nuclei (LHb and MHb) may have differ-
ent impact on behavior and drug intake. This difference might 
depend on their particular function, the circadian properties of 
each structure (i.e., period, phase, and amplitude), and/or the 
time of drug exposure.
The Circadian Clock in the Lateral 
Habenula
Beyond the role of the Hb on behavioral control, recent 
data have shown an implication of the Hb in the regula-
tion of sleep and circadian rhythms. Electrophysiological 
recordings showed that both LHb and MHb cells present a 
circadian variation of their spontaneous firing rate [(64–67); 
Figure  2]. This rhythmic activity disappears in both the 
MHb and LHb in animals with a molecular circadian clock 
mutation (65, 66).
FiGURe 2 | Circadian circuitry of LHb for the control of behavior. The circadian oscillator in the LHb may be affected by light information from retinal 
projections (in bold), which arrive at the border of the LHb. The main SCN clock contacts the LHb by a direct neural pathway in which PK2 is positioned as the main 
clock-output factor. However, possible indirect pathways via the pineal gland, raphe nuclei, or BNST may link the SCN to the LHb as well. The LHB modulates 
midbrain DA activity from the VTA, and reciprocally DA may affect LHb activity. Under normal conditions (black oscillation), this pathway may result in a circadian 
release of DA in the striatum and several behavioral outputs, such as motivated behavior, voluntary motor activity, or sleep–wake cycles. On the other hand, under 
acute cocaine conditions, circadian rhythms of the LHb may change in amplitude, phase, or period (pink oscillations), which can lead in modifications of the VTA 
activity. However, under chronic cocaine situations beyond changes in LHb oscillations, denervations of the FR (pink cross) may lead to a dysregulation in the 
DAergic system and related behavioral outputs. Thus, symptoms of addictive behaviors may appear due to loss of rhythmic control of LHb. 3V, ventral third 
ventricule; BNST, bed nucleus of the stria terminalis; D3V, dorsal third ventricule; OC, optic chiasma.
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Other studies report the expression of Per1–2 and Clock mRNA 
and protein in the whole Hb complex (68, 69). Using transgenic 
mice in which a luciferase reporter is coupled to the protein PER2, 
authors showed that the expression of PER2 in a small selected 
part in the mid-LHb has a sustained rhythmic activity (64). 
Moreover, c-Fos expression in the LHb is also rhythmic in mice, 
hamsters, and rats (70). Interestingly, denervations of the FR, the 
main output of the LHb, alter the circadian rest-activity cycle in 
hamsters (71). Thus, the LHb clock modulates the intensity or 
amount of activity in the day–night rhythms of locomotion.
The LHb receives environmental light information from 
melanopsin ganglion cells of the retina that project to the border 
of the LHb; thus, some interneurons may link the retino-LHb 
pathway [(72); Figure 2]. In addition, firing rate of LHb cells is 
affected by light in vivo, and this photic response is significantly 
larger in amplitude in LHb cells during the night than during the 
day (67).
The SCN clock innervates the LHb (Figure 2). The SCN uses 
different neuropeptide, such as vasopressin, vasoactive intestinal 
peptide, and prokineticin 2 (PK2), to communicate time infor-
mation to other brain structures (73). The LHb receives PK2 
fibers from the SCN and contains PK2 receptors [(74); Figure 2]. 
A recent study reported that PK2 is able to inhibit the LHb firing 
rate in vitro (66). Some vasopressin fibers run around the ventral 
part of the LHb even in SCN-lesioned rats, suggesting that vaso-
pressin source might come from other brain structure (75); the 
bed nucleus of the stria terminalis, or the paraventricular nucleus 
of the hypothalamus (76) for example.
An indirect pathway can drive the message from the SCN to 
the LHb by a hormonal input (e.g., melatonin), or by a neuronal 
pathway with an intermediate structure, such as the raphe nuclei 
that project to both the SCN and LHb [(77–79); Figure  2]. 
Interestingly, serotonin release from the raphe nuclei is also 
rhythmic; it modulates SCN activity and dampens excitatory 
inputs from the basal ganglia to the LHb (54, 80, 81). Thus, 
serotonin may be a good candidate to modulate the rhythmic 
activity of the LHb. Reciprocally, the LHb projects to the raphe 
nuclei (82), and drugs of abuse act on serotonin transporters 
(83). Serotonin levels are altered in depression and mood signs 
are often associated symptoms of addicted behaviors. Therefore, 
the mood changes during addiction may be dependent on dis-
turbance in the circadian link between the LHb and the raphe 
nuclei (84).
what May Be the Clock-Outputs of the 
LHb to Control Rhythmic Drug intake?
The VTA expresses clock genes and tyrosine hydroxylase (the 
limiting enzyme in DA synthesis) co-localizes with clock proteins 
[REV-ERB, BMAL1, PER1; (85–87)]. DA release and cell firing 
in the VTA are rhythmic (88–90). Moreover, the PER2 protein 
expression in the striatum follows a circadian rhythm (peak of 
expression rises at night) that is entrained by DA via D2 type 
receptors (91). However, in isolated cultured VTA from Per1: 
Luciferase rats, no oscillations were found (92). Thus, VTA 
circadian oscillations must be under the control of a brain self-
sustained circadian oscillator.
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Day–night differences of tyrosine hydroxylase and DA 
transporter in striatum are dampened but not abolished in SCN-
lesioned rats (93). Therefore, another circadian clock beyond the 
SCN regulates rhythmic activity of the DAergic system. The LHb 
clock could play an important role for the regulation of DAergic 
rhythms (Figure 2).
The circadian role of the LHb might be to inhibit DAergic 
neurons at a specific time during the 24-h cycle. In rats, the LHb 
peak of electrical activity occurs during the day, when the release 
of DA to the striatum is low (67, 91). In mice, however, there 
is a circadian rhythm of LHb firing rate with a peak at night 
time, which correlates with VTA lower electrical activity (64, 
94). Thus, it is necessary to determine the circadian activity (i.e., 
firing rate, clock gene expression) of the LHb in vivo in both rats 
and mice.
Since LHb activity controls DA neuronal activity, it is also 
possible that LHb modulates rhythmic behaviors related to 
drug intake through the regulation of the DAergic system. In 
fact, behavioral sensitization [which has a rhythmic profile; (15, 
16)] is altered by LHb lesions in rats (95). This suggests that the 
LHb clock could modulate the rhythmic patterns of behavioral 
sensitization or reward effects of cocaine. Moreover, cocaine self-
administration shows a daily rhythm in phase (with a maximum 
at the night) with the peak of DA release in the striatum. Both 
self-administration and DA release are correlated with the high-
est LHb firing rate (20, 23, 67, 91). Importantly, chronic intake 
of cocaine, which leads to FR degeneration, is able to disrupt 
circadian rhythms probably due to the lack of LHb control on 
monoamine nuclei [(20, 96); Figure 2].
Possible Therapies for Addiction: The 
Habenula as a Target
Low frequency stimulations, which mimic inputs from the VTA 
or raphe nucleus to the LHb, inhibit the LHb activity and induce 
cocaine intake in rats (35–38, 60). However, high frequencies, 
which mimic aversive and excitatory input from the basal ganglia, 
do not reduce cocaine intake (35–38, 60). Interestingly, deep brain 
stimulation (DBS) is associated with reward and aversive inputs 
(low and high frequencies), and reduces cocaine consumption in 
rats (60). DBS is a technical approach that has been used for the 
treatment of some psychiatric disorders, such as depression and 
obsessive–compulsive disorder (97).
The LHb has been proposed as a target for DBS to treat 
addiction because of its close functional relationship with the 
reward system (98). However, chronic exposure to cocaine, 
amphetamine, methamphetamine, MDMA, or nicotine results 
in the degeneration of the FR, which blocks the effect of DBS 
on drug intake (96, 99, 100). As long as FR is able to transmit 
information, the LHb can be considered as a main target for DBS 
in the treatment of addiction. Moreover, if circadian properties 
of the LHb are an important factor for DBS, it then becomes 
possible to potentiate the beneficial effect, or avoid side effects 
of DBS, by applying stimulation at a specific time of the day 
and consider a genuine type of DBS chronotherapy (i.e., time-
dependent treatment).
Despite the prominent actions of DBS as a treatment, the 
technique still remains an invasive approach that may produce 
side effects. Therefore, other alternative treatments for addiction 
have to be considered.
In chronic drug intake, degeneration of FR may be due, in part, 
to a reduction of the GABA receptors expression, leading to a LHb 
disinhibition, and an increase of glutamate receptors allowing an 
excitotoxic effect on LHb cells (58, 96, 99). LHb disinhibition 
may be restored by a GABAB receptor agonist, a molecule that 
is already proposed as a possible treatment for drug addiction 
(101). Hence, LHb inhibition by GABA agonists at the circadian 
optimal time could rescue a daily rhythm of LHb activity and 
reduce addiction states.
The Hb expresses melatonin receptors (102) and projects 
to the pineal gland, the site of melatonin production (103). 
Melatonin receptors mediate the behavioral sensitization to 
methamphetamine (104). Moreover, activation of melatonin 
receptors (with melatonin or the agonist agomelatine) reduces 
relapse-like alcohol intake in rats (105). More importantly, since 
there is a strong rhythmic activity of melatonin, it is possible that 
the effects of the hormone on the circadian activity of the Hb are 
phase (time)-dependent. Thus, melatonin might have effects to 
modulate drug-seeking and intake via an activation of its recep-
tors in the Hb at specific times of the day.
COnCLUSiOn
In this review, we addressed the circadian relevance of the LHb 
for the regulation of rhythmic brain activity and behavior. This 
work may help to understand the role of LHb, as a circadian 
clock, in the development of psychiatric pathologies and addic-
tion. The vast literature devoted to LHb indicates that these 
nuclei have a relevant role in different brain functions, and dys-
functions (e.g., depression and addiction) (106). Some studies 
also highlight the clock properties of the LHb in the regulation 
of behavior (70, 71, 107). Therefore, to understand the specific 
neurobiological role of the Hb (both the MHb and LHb nuclei) 
in brain physiology and pathophysiological conditions, the 
circadian properties of this brain locus should be considered as 
an important factor.
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